The Pre-Filled Syringes market is estimated at US$5,069.3 million in 2024 and is expected to register a CAGR of 9.5% from 2024 to 2034.

Thus, the high demand for pre-filled syringes intended for the administration of COVID-19 vaccines is expected to fuel the market growth during the forecast period.

Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved the Company's New Drug Application for Epinephrine injection USP, 1 mg/10mL Single Dose Pre-Filled ...

Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 4th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April ...